{"id":"AGY-FED-HEALTH-OTHER-013","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","eco":"","issuer":"Drug Enforcement Administration, Diversion Control Division","authority":"21 U.S.C. 829(a); 21 C.F.R. 1306.11(d), 290.10; 21 C.F.R. 1307.03","instrument":"DEA-DC-021 (DEA073), letter to practitioner registrants and pharmacists announcing temporary exceptions for oral schedule II prescriptions in emergency situations during the COVID-19 emergency","title":"Oral CII for regular CII script (Final)","dateIssued":"2020-03-27","effective":"2020-03-27 (digitally signed Mar. 28, 2020)","end":"For the duration of the public health emergency (unless modified or withdrawn by DEA)","startDate":"2020-03-27","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"addressees":["practitioner registrants","pharmacists"],"clause":"DEA provides the following guidance on this topic and announces temporary exceptions. These exceptions shall remain in place for the duration of the Public Health Emergency (unless modified or withdrawn by DEA).... DEA acknowledges, however, that the Public Health Emergency is likely creating emergency situations, as defined by 21 CFR 290.10, with increased frequency.","enforcement":"Prescription-form requirements under 21 U.S.C. 829(a) and 842","functions":["CL clinical prescribing","RT pharmacy dispensing","CB patients"],"notes":"Extended the seven-day period for delivering the written follow-up prescription to fifteen days and permitted photographed or scanned prescriptions to the pharmacy.","sourceUrl":"https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-021)(DEA073)%20Oral%20CII%20for%20regular%20CII%20scirpt%20(Final)%20+Esign%20a.pdf","snapshot":"https://web.archive.org/web/20200407080556/https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-021)(DEA073)%20Oral%20CII%20for%20regular%20CII%20scirpt%20(Final)%20+Esign%20a.pdf","fileExists":true,"fileBytes":193088,"grade":"primary","character":"","description":"","collection":"AGY-FED-HEALTH-OTHER","url":"/library/AGY-FED-HEALTH-OTHER-013","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-013","citation":"Drug Enforcement Administration, Diversion Control Division, DEA-DC-021 (DEA073), letter to practitioner registrants and pharmacists announcing temporary exceptions for oral schedule II prescriptions in emergency situations during the COVID-19 emergency (Mar. 27, 2020) (Ex. AGY-FED-HEALTH-OTHER-013)","stateName":"","related":["AGY-FED-HEALTH-OTHER-015"]}